These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 18835029)
1. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Ruiz i Altaba A Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029 [TBL] [Abstract][Full Text] [Related]
2. Targeting GLI factors to inhibit the Hedgehog pathway. Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120 [TBL] [Abstract][Full Text] [Related]
3. Nonclassical hedgehog-GLI signaling and its clinical implications. Shevde LA; Samant RS Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208 [TBL] [Abstract][Full Text] [Related]
4. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors. Arnhold V; Boos J; Lanvers-Kaminsky C Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311 [TBL] [Abstract][Full Text] [Related]
5. The presence of primary cilia in cancer cells does not predict responsiveness to modulation of smoothened activity. Spann AL; Yuan K; Goliwas KF; Steg AD; Kaushik DD; Kwon YJ; Frost AR Int J Oncol; 2015 Jul; 47(1):269-79. PubMed ID: 25997440 [TBL] [Abstract][Full Text] [Related]
6. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y Oncology; 2006; 70(5):378-89. PubMed ID: 17179732 [TBL] [Abstract][Full Text] [Related]
8. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. Varnat F; Duquet A; Malerba M; Zbinden M; Mas C; Gervaz P; Ruiz i Altaba A EMBO Mol Med; 2009 Sep; 1(6-7):338-51. PubMed ID: 20049737 [TBL] [Abstract][Full Text] [Related]
9. Gli as a novel therapeutic target in malignant pleural mesothelioma. Li H; Lui N; Cheng T; Tseng HH; Yue D; Giroux-Leprieur E; Do HT; Sheng Q; Jin JQ; Luh TW; Jablons DM; He B PLoS One; 2013; 8(3):e57346. PubMed ID: 23483902 [TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Ruiz i Altaba A Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144 [TBL] [Abstract][Full Text] [Related]
11. Targeting GLI Transcription Factors in Cancer. Didiasova M; Schaefer L; Wygrecka M Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137 [TBL] [Abstract][Full Text] [Related]
12. Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1. Nayak A; Satapathy SR; Das D; Siddharth S; Tripathi N; Bharatam PV; Kundu C Sci Rep; 2016 Feb; 6():20600. PubMed ID: 26846872 [TBL] [Abstract][Full Text] [Related]
13. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Amakye D; Jagani Z; Dorsch M Nat Med; 2013 Nov; 19(11):1410-22. PubMed ID: 24202394 [TBL] [Abstract][Full Text] [Related]
14. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling. Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295 [TBL] [Abstract][Full Text] [Related]
15. Scaffold hopping approach to a new series of smoothened antagonists. Lu W; Geng D; Sun Z; Yang Z; Ma H; Zheng J; Zhang X Bioorg Med Chem Lett; 2014 May; 24(10):2300-4. PubMed ID: 24726807 [TBL] [Abstract][Full Text] [Related]
16. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma. Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134 [TBL] [Abstract][Full Text] [Related]